Fiera Capital Corp Purchases 169,830 Shares of CME Group Inc (NASDAQ:CME)

Fiera Capital Corp lifted its position in shares of CME Group Inc (NASDAQ:CME) by 7.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,531,242 shares of the financial services provider’s stock after purchasing an additional 169,830 shares during the period. CME Group accounts for 1.6% of Fiera Capital Corp’s portfolio, making the stock its 22nd largest holding. Fiera Capital Corp owned 0.71% of CME Group worth $416,592,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Dubuque Bank & Trust Co. boosted its position in shares of CME Group by 83.1% in the first quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 69 shares during the period. Resources Investment Advisors Inc. lifted its position in CME Group by 2,800.0% during the fourth quarter. Resources Investment Advisors Inc. now owns 145 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 140 shares during the last quarter. Smith Asset Management Group LP lifted its holdings in shares of CME Group by 200.0% in the 4th quarter. Smith Asset Management Group LP now owns 150 shares of the financial services provider’s stock worth $28,000 after acquiring an additional 100 shares during the last quarter. Truvestments Capital LLC bought a new stake in shares of CME Group in the 1st quarter worth approximately $32,000. Finally, Close Asset Management Ltd bought a new stake in shares of CME Group in the 1st quarter worth approximately $34,000. Institutional investors own 84.67% of the company’s stock.

A number of research analysts have issued reports on CME shares. Deutsche Bank reduced their price objective on shares of CME Group from $220.00 to $214.00 and set a “buy” rating on the stock in a research report on Friday, March 15th. Citigroup set a $202.00 price target on CME Group and gave the stock a “buy” rating in a report on Thursday, May 2nd. ValuEngine upgraded CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, May 8th. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a report on Tuesday, May 14th. Finally, Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a research note on Wednesday, April 17th. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and eight have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $188.87.

In related news, insider Derek Sammann sold 6,400 shares of the business’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $198.83, for a total value of $1,272,512.00. Following the completion of the sale, the insider now directly owns 25,177 shares of the company’s stock, valued at $5,005,942.91. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO John W. Pietrowicz sold 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, April 3rd. The shares were sold at an average price of $168.27, for a total value of $420,675.00. Following the transaction, the chief financial officer now directly owns 35,354 shares of the company’s stock, valued at $5,949,017.58. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 48,873 shares of company stock worth $9,385,174. 1.20% of the stock is currently owned by insiders.

CME Group stock traded up $2.48 during mid-day trading on Monday, hitting $196.59. 942,948 shares of the company were exchanged, compared to its average volume of 1,710,340. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a 50 day moving average price of $193.01. The firm has a market cap of $69.30 billion, a P/E ratio of 28.83, a P/E/G ratio of 4.43 and a beta of 0.23. CME Group Inc has a 12-month low of $158.35 and a 12-month high of $204.56.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.62 EPS for the quarter, beating the Zacks’ consensus estimate of $1.60 by $0.02. The business had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.19 billion. CME Group had a return on equity of 9.29% and a net margin of 42.47%. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.86 earnings per share. Analysts forecast that CME Group Inc will post 6.64 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 10th were paid a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date of this dividend was Friday, June 7th. CME Group’s dividend payout ratio is presently 43.99%.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: Front-End Load

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.